Atara Biotherapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Hello everybody. And welcome to our Fireside with Atara. Mike and I are hosting management, we have Pascal and Jakob here with us today. We're so happy to have you here to answer our questions, so welcome. Pascal, why don't you to lead us off. I understand you've got a few introductory remarks.
Yes. Good morning all. Pleasure to be with you. Atara Biotherapeutics is truly a leader in off-the-shelf Allogeneic T-cell Immunotherapy with five key unique features.
First we have a differentiated Allogeneic Cell Therapy Platform which is scalable, we know how to make this allogeneic cell in terms of thousands of patients not only a few hundred of patients, and tens of thousands of patients as well.
It's also flexible in the sense that we can make different types of allogeneic T cell therapies, so differentiated allogeneic cell therapy platform.
We're also the first-in-kind late-stage oncology asset Tab-cel with BTD,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |